Xuan Marian Thai

Array ( [id] => 5023484 [patent_doc_number] => 20070149450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Method for reducing levels of c-reactive protein' [patent_app_type] => utility [patent_app_number] => 10/546728 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8670 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149450.pdf [firstpage_image] =>[orig_patent_app_number] => 10546728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119932 [patent_doc_number] => 20070141646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents' [patent_app_type] => utility [patent_app_number] => 10/545721 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6272 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141646.pdf [firstpage_image] =>[orig_patent_app_number] => 10545721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 295766 [patent_doc_number] => 07541033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Humanized anti-IL-1β antibodies' [patent_app_type] => utility [patent_app_number] => 10/542508 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13789 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541033.pdf [firstpage_image] =>[orig_patent_app_number] => 10542508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4984642 [patent_doc_number] => 20070089201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Plant production of immunoglobulins with reduced fucosylation' [patent_app_type] => utility [patent_app_number] => 10/536875 [patent_app_country] => US [patent_app_date] => 2003-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 34872 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20070089201.pdf [firstpage_image] =>[orig_patent_app_number] => 10536875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667024 [patent_doc_number] => 20060172374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Phosphorylated ndr kinase' [patent_app_type] => utility [patent_app_number] => 10/535920 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13712 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172374.pdf [firstpage_image] =>[orig_patent_app_number] => 10535920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105096 [patent_doc_number] => 20050107319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method of inhibiting factor B-mediated complement activation, and the uses thereof' [patent_app_type] => utility [patent_app_number] => 10/716929 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8349 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107319.pdf [firstpage_image] =>[orig_patent_app_number] => 10716929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859130 [patent_doc_number] => 20080267980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Complement Receptor 2 Targeted Complement Modulators' [patent_app_type] => utility [patent_app_number] => 10/534772 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 37141 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267980.pdf [firstpage_image] =>[orig_patent_app_number] => 10534772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 563880 [patent_doc_number] => 07465547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Methods for detecting human low molecular weight CD14' [patent_app_type] => utility [patent_app_number] => 10/534257 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27895 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465547.pdf [firstpage_image] =>[orig_patent_app_number] => 10534257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236443 [patent_doc_number] => 20070128600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Alpha macroglobulin family member' [patent_app_type] => utility [patent_app_number] => 10/534242 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23731 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128600.pdf [firstpage_image] =>[orig_patent_app_number] => 10534242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872892 [patent_doc_number] => 20060165676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Identification of tsh receptor autoantibodies using affinity-purified antibodies' [patent_app_type] => utility [patent_app_number] => 10/536577 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5472 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165676.pdf [firstpage_image] =>[orig_patent_app_number] => 10536577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5709999 [patent_doc_number] => 20060051344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Antibody and utilization of the same' [patent_app_type] => utility [patent_app_number] => 10/532452 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14014 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051344.pdf [firstpage_image] =>[orig_patent_app_number] => 10532452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046124 [patent_doc_number] => 20050250719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 10/528806 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10767 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250719.pdf [firstpage_image] =>[orig_patent_app_number] => 10528806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 170731 [patent_doc_number] => 07662772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Methods for treating congestive heart failure' [patent_app_type] => utility [patent_app_number] => 10/646268 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 40 [patent_no_of_words] => 14331 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662772.pdf [firstpage_image] =>[orig_patent_app_number] => 10646268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909207 [patent_doc_number] => 20080019973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Methods for Treating Ocular Inflammation by Neutralizing Cxcl10 Activity' [patent_app_type] => utility [patent_app_number] => 10/549482 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19026 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019973.pdf [firstpage_image] =>[orig_patent_app_number] => 10549482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281489 [patent_doc_number] => 07553488 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions' [patent_app_type] => utility [patent_app_number] => 10/517319 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10198 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553488.pdf [firstpage_image] =>[orig_patent_app_number] => 10517319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136498 [patent_doc_number] => 20040044076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Neutrophil imaging methods in cystic fibrosis' [patent_app_type] => new [patent_app_number] => 10/452925 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13774 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044076.pdf [firstpage_image] =>[orig_patent_app_number] => 10452925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 70867 [patent_doc_number] => 07754216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Method of treating multiple sclerosis with anti-K6 antibody' [patent_app_type] => utility [patent_app_number] => 10/514687 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21163 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754216.pdf [firstpage_image] =>[orig_patent_app_number] => 10514687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625855 [patent_doc_number] => 20060264360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Anti-inflammatory and wound healing effects of lymphoid thymosin beta-4' [patent_app_type] => utility [patent_app_number] => 10/510569 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15259 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264360.pdf [firstpage_image] =>[orig_patent_app_number] => 10510569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952847 [patent_doc_number] => 20050227942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Method and agent for the prevention, inhibition and treatment of sepsis' [patent_app_type] => utility [patent_app_number] => 10/516619 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5930 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227942.pdf [firstpage_image] =>[orig_patent_app_number] => 10516619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6917681 [patent_doc_number] => 20050095242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Diagnostics and remedies for interstitial pneumonia' [patent_app_type] => utility [patent_app_number] => 10/505980 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29272 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095242.pdf [firstpage_image] =>[orig_patent_app_number] => 10505980 [rel_patent_id] =>[rel_patent_doc_number] =>)